The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
Dong Hoe Koo
No relevant relationships to disclose
Min-Hee Ryu
No relevant relationships to disclose
Baek-Yeol Ryoo
No relevant relationships to disclose
Mo Youl Beck
No relevant relationships to disclose
Young-Soon Na
No relevant relationships to disclose
Jae-Gook Shin
No relevant relationships to disclose
Sang Seop Lee
No relevant relationships to disclose
Eun-Young Kim
No relevant relationships to disclose
Yoon-Koo Kang
Honoraria - Novartis
Research Funding - Novartis